الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 127 |  |  |
| | | from | 127 | | |
Abstract
This study indicates that P. multocida remains a serious problem in poultry farms in Egypt. Therefore, prevention and control of fowl cholera should be applied by effective treatment, biosecurity measures, vaccination and reduction of predisposing factors.
Since the isolates are resistant to a panel of commercial antimicrobial agents. Extensive use of antimicrobials bears a high risk of selecting resistant bacteria, promoting the spread of resistance genes, and consequently, reducing the efficacy of the antimicrobial agents currently available for the treatment of the disease. Consequently, it is necessary to pretest antimicrobial efficacy against Pasteurella to identify the most effective antimicrobial agents that should be used for therapeutic use. Moreover, it is mandatory to change the use of antimicrobials for prophylaxis and at subtherapeutic levels in chicken feed as growth promoters.
PM-PCR and capsular PCR are efficient assays for rapid precise identification and serogrouping of P. multocida to reform fowl cholera diagnosis. Also, Capsular PCR based serogrouping can be an alternate in countries which are currently not able to perform the conventional serotyping and in epidemiological studies.